Mindray's Collaboration with Edwards Lifesciences Marks the First Integration of The FloTrac™ Sensor for Multiparameter Bedside Monitoring
MAHWAH, N.J., Oct. 12, 2023 /PRNewswire/ -- Mindray, a global leader and developer of healthcare solutions and technologies in ultrasound, patient monitoring, and anesthesia, announced a new milestone in their cooperative agreement with Edwards Lifesciences, a global leader in medical innovations for structural heart disease and critical care monitoring. This milestone provides a solution that makes Mindray's BeneVision N-Series the first patient monitoring system to integrate with Edwards FloTrac™ sensor for hemodynamic monitoring in the North American market, following their launch in China in 2022.
- This milestone provides a solution that makes Mindray's BeneVision N-Series the first patient monitoring system to integrate with Edwards FloTrac™ sensor for hemodynamic monitoring in the North American market, following their launch in China in 2022.
- Mindray's BeneVision N-Series is the first patient monitoring platform to integrate Edwards' FloTrac™ sensor.
- The continuous monitoring of pressure and flow parameters is essential for managing hemodynamically unstable patients to guide appropriate treatment.
- This collaboration is a testament to the companies' commitment to improving clinical decision-making, productivity, and ultimately advancing patient care.